True Durability
HIV Virologic Suppression in an Urban Clinic and Implications for Timing of Intensive Adherence Efforts and Viral Load Monitoring
Bibliographic Data
| ID | 15337495 |
|---|---|
| Authors | Debra Benator (Veterans Health Administration, corresponding author), Debra A Benator, Angelo Elmi (0000-0002-5786-5801, Milken Institute), Manuel de Buenaga Rodríguez (0000-0003-4705-1836, George Washington University), Manuel D Rodriguez, Howard B Gale (Veterans Health Administration), Virginia L Kan (0000-0001-7569-2740, George Washington University), Heather J Hoffman (Milken Institute), Susan Tramazzo (Veterans Health Administration), Karen Hall (0000-0001-7812-4810), Karen E Hall (Veterans Health Administration), Angela McKnight (Veterans Health Administration), Leah Squires (Veterans Health Administration) |
| Year | 2014 |
| Volume | 19 |
| Issue | 4 |
| Pages | 594-600 |
| Publication date | 2014-11-04 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | AIDS and Behavior (JOURNAL) |
| Journal identifiers | ISSN: 1090-7165 • E-ISSN: 1573-3254 |
| Publisher | Springer Science+Business Media (PUBLISHER • DE) |
| DOI | 10.1007/s10461-014-0917-6 |
| PMID | 25369887 |
| PMCID | PMC4392112 |
| OpenAlex | W2007513939 |
| Language | EN |
| Citations received | 6 |
| References cited | 19 |
Although the majority of HIV-infected patients who begin potent antiretroviral therapy should expect long-term virologic suppression, the realities in practice are less certain. Durability of viral suppression was examined to define the best timing of targeted adherence strategies and intensive viral load monitoring in an urban clinic population with multiple challenges to ART adherence. We examined the risk of viral rebound for patients who achieved two consecutive viral loads lower than the lower limit of quantification (LLOQ) within 390 days. For 791 patients with two viral loads below the LLOQ, viral rebound >LLOQ from the first viral load was 36.9 % (95 % CI 32.2-41.6) in the first year, 26.9 % (95 % CI 21.7-32.1) in the year following one year of viral suppression, and 24.6 % (95 % CI 18.4-30.9) in the year following 2 years of viral suppression. However, for patients with CD4 ≥300 cells/μl who had 3-6 years of virologic suppression, the risk of viral rebound was very low. At the population level, the risk of viral rebound in a complex urban clinic population is surprisingly high even out to 3 years. Intensified monitoring and adherence efforts should target this high risk period. Thereafter, confidence in truly durable virologic suppression is improved
Durability · Health psychology · Human immunodeficiency virus (HIV · Intensive care medicine · Public health · Viral load · Computer Science · HIV Research and Treatment · HIV/AIDS drug development and treatment · HIV/AIDS Research and Interventions · Medicine · Nursing · Immunology · Virology
Disparities in achieving and sustaining viral suppression among a large cohort of HIV-infected persons in care – Washington, DC
Growing challenges for HIV programmes in Asia
Longitudinal assessments of viral rebound among people with HIV in South Carolina
Acceptability of Long-Acting Injectable Antiretroviral Therapy Among People with HIV Receiving Care at Three Ryan White Funded Clinics in the United States
Understanding the Risk of Human Immunodeficiency Virus (HIV) Virologic Failure in the Era of Undetectable Equals Untransmittable
An Exploration of Syndemic Factors That Influence Engagement in HIV Care Among Black Men
| Citations per year | 0.6 |
|---|---|
| Citation span | 2016 - 2025 (10) |
| Highly cited | No |